Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Surgery Partners Inc.

    NASDAQ: SGRY · Real-Time Price · USD
    19.30
    -0.54 (-2.70%)
    At close: Jun 20, 2025, 3:59 PM
    19.51
    1.06%
    After-hours: Jun 20, 2025, 04:37 PM EDT

    Surgery Partners Statistics

    Share Statistics

    Surgery Partners has 128.16M shares outstanding. The number of shares has increased by 0.41% in one year.

    Shares Outstanding

    n/a
    		 128.16M

    Shares Change (YoY)

    n/a
    		 0.41%

    Shares Change (QoQ)

    n/a
    		 0.39%

    Owned by Institutions (%)

    n/a
    		 99.99%

    Shares Floating

    n/a
    		 75.9M

    Failed to Deliver (FTD) Shares

    n/a
    		 27

    FTD / Avg. Volume

    n/a
    		 n/a

    Short Selling Information

    The latest short interest is 9.36M, so 7.31% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 9.36M

    Short % of Shares Out

    n/a
    		 7.31%

    Short % of Float

    n/a
    		 15.5%

    Short Ratio (days to cover)

    n/a
    		 8.79

    Valuation Ratios

    The PE ratio is -15.88 and the forward PE ratio is 16.24. Surgery Partners's PEG ratio is -0.01.

    PE Ratio

    n/a
    		 -15.88

    Forward PE

    n/a
    		 16.24

    PS Ratio

    n/a
    		 0.86

    Forward PS

    n/a
    		 0.5

    PB Ratio

    n/a
    		 1.49

    P/FCF Ratio

    n/a
    		 12.73

    PEG Ratio

    n/a
    		 -0.01
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Surgery Partners.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 1.79, with a Debt / Equity ratio of 2.07.

    Current Ratio

    n/a
    		 1.79

    Quick Ratio

    n/a
    		 1.65

    Debt / Equity

    n/a
    		 2.07

    Debt / EBITDA

    n/a
    		 7.39

    Debt / FCF

    n/a
    		 17.66

    Interest Coverage

    n/a
    		 1.73

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 $207,620

    Profits Per Employee

    n/a
    		 $-11,206.67

    Employee Count

    n/a
    		 15,000

    Asset Turnover

    n/a
    		 0.39

    Inventory Turnover

    n/a
    		 26.8

    Taxes

    Income Tax

    n/a
    		 134.6M

    Effective Tax Rate

    n/a
    		 91.5%

    Stock Price Statistics

    The stock price has increased by -16.25% in the last 52 weeks. The beta is 1.94, so Surgery Partners's price volatility has been higher than the market average.

    Beta

    n/a
    		 1.94

    52-Week Price Change

    n/a
    		 -16.25%

    50-Day Moving Average

    n/a
    		 22.37

    200-Day Moving Average

    n/a
    		 24.96

    Relative Strength Index (RSI)

    n/a
    		 26.96

    Average Volume (20 Days)

    n/a
    		 1,178,511

    Income Statement

    In the last 12 months, Surgery Partners had revenue of 3.11B and earned -168.1M in profits. Earnings per share was -1.33.

    Revenue

    n/a
    		 3.11B

    Gross Profit

    n/a
    		 745.6M

    Operating Income

    n/a
    		 348.8M

    Net Income

    n/a
    		 -168.1M

    EBITDA

    n/a
    		 501.4M

    EBIT

    n/a
    		 348.8M

    Earnings Per Share (EPS)

    n/a
    		 -1.33
    Full Income Statement

    Balance Sheet

    The company has 269.5M in cash and 3.7B in debt, giving a net cash position of -3.43B.

    Cash & Cash Equivalents

    n/a
    		 269.5M

    Total Debt

    n/a
    		 3.7B

    Net Cash

    n/a
    		 -3.43B

    Retained Earnings

    n/a
    		 -737.3M

    Total Assets

    n/a
    		 7.95B

    Working Capital

    n/a
    		 505.2M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was 300.1M and capital expenditures -90.4M, giving a free cash flow of 209.7M.

    Operating Cash Flow

    n/a
    		 300.1M

    Capital Expenditures

    n/a
    		 -90.4M

    Free Cash Flow

    n/a
    		 209.7M

    FCF Per Share

    n/a
    		 1.66
    Full Cash Flow Statement

    Margins

    Gross margin is 23.94%, with operating and profit margins of 11.2% and -5.4%.

    Gross Margin

    n/a
    		 23.94%

    Operating Margin

    n/a
    		 11.2%

    Pretax Margin

    n/a
    		 4.72%

    Profit Margin

    n/a
    		 -5.4%

    EBITDA Margin

    n/a
    		 16.1%

    EBIT Margin

    n/a
    		 11.2%

    FCF Margin

    n/a
    		 6.73%

    Dividends & Yields

    SGRY does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for SGRY is $35, which is 76.4% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $35

    Price Target Difference

    n/a
    		 76.4%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 9
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Scores

    Altman Z-Score

    n/a
    		 0.88

    Piotroski F-Score

    n/a
    		 4

    Add to Watchlist